Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Learn the essential systems for your homestead and the best sequence to install them efficiently. Tips and insights for off-grid living and sustainable setups. #HomesteadTips #OffGridLiving ...
GlobalData on MSN
Construction begins on Engie’s Pelican Point BESS in South Australia
The hybrid operational model integrates the site's upgraded gas plant with the new battery system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback